Annual Operating Expenses
$16.42 B
+$763.00 M+4.87%
December 1, 2024
Summary
- As of February 26, 2025, ABT annual total operating expenses is $16.42 billion, with the most recent change of +$763.00 million (+4.87%) on December 1, 2024.
- During the last 3 years, ABT annual operating expenses has risen by +$306.00 million (+1.90%).
- ABT annual operating expenses is now at all-time high.
Performance
ABT Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$4.12 B
+$43.00 M+1.05%
December 1, 2024
Summary
- As of February 26, 2025, ABT quarterly total operating expenses is $4.12 billion, with the most recent change of +$43.00 million (+1.05%) on December 1, 2024.
- Over the past year, ABT quarterly operating expenses has increased by +$216.00 million (+5.53%).
- ABT quarterly operating expenses is now -21.48% below its all-time high of $5.25 billion, reached on September 30, 2011.
Performance
ABT Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ABT Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.9% | +5.5% |
| 3 y3 years | +1.9% | +5.5% |
| 5 y5 years | +16.1% | +5.5% |
ABT Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +4.9% | -4.7% | +5.9% |
| 5 y | 5-year | at high | +16.1% | -4.7% | +21.5% |
| alltime | all time | at high | +1557.2% | -21.5% | +234.3% |
Abbott Laboratories Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $16.42 B(+4.9%) | $4.12 B(+1.1%) |
| Sep 2024 | - | $4.08 B(-0.7%) |
| Jun 2024 | - | $4.11 B(-0.2%) |
| Mar 2024 | - | $4.12 B(+5.4%) |
| Dec 2023 | $15.66 B(-3.1%) | $3.90 B(+0.4%) |
| Sep 2023 | - | $3.89 B(-1.6%) |
| Jun 2023 | - | $3.95 B(+1.2%) |
| Mar 2023 | - | $3.91 B(-6.8%) |
| Dec 2022 | $16.15 B(+0.2%) | $4.19 B(+4.6%) |
| Sep 2022 | - | $4.01 B(+1.6%) |
| Jun 2022 | - | $3.95 B(-1.2%) |
| Mar 2022 | - | $4.00 B(-7.6%) |
| Dec 2021 | $16.11 B(+13.1%) | $4.32 B(+9.2%) |
| Sep 2021 | - | $3.96 B(+1.9%) |
| Jun 2021 | - | $3.88 B(-1.6%) |
| Mar 2021 | - | $3.95 B(+4.5%) |
| Dec 2020 | $14.25 B(+0.8%) | $3.78 B(+11.3%) |
| Sep 2020 | - | $3.39 B(-0.0%) |
| Jun 2020 | - | $3.39 B(-8.0%) |
| Mar 2020 | - | $3.69 B(+5.6%) |
| Dec 2019 | $14.14 B(-0.6%) | $3.49 B(-0.8%) |
| Sep 2019 | - | $3.52 B(+0.7%) |
| Jun 2019 | - | $3.49 B(-3.9%) |
| Mar 2019 | - | $3.64 B(+6.7%) |
| Dec 2018 | $14.22 B(+6.0%) | $3.41 B(-2.5%) |
| Sep 2018 | - | $3.50 B(-3.0%) |
| Jun 2018 | - | $3.60 B(-3.0%) |
| Mar 2018 | - | $3.71 B(+1.6%) |
| Dec 2017 | $13.42 B(+53.6%) | $3.66 B(+14.8%) |
| Sep 2017 | - | $3.18 B(+4.0%) |
| Jun 2017 | - | $3.06 B(-12.9%) |
| Mar 2017 | - | $3.52 B(+62.6%) |
| Dec 2016 | $8.73 B(-0.7%) | $2.16 B(+2.0%) |
| Sep 2016 | - | $2.12 B(-4.9%) |
| Jun 2016 | - | $2.23 B(+0.4%) |
| Mar 2016 | - | $2.22 B(+2.5%) |
| Dec 2015 | $8.79 B(+4.3%) | $2.17 B(-1.3%) |
| Sep 2015 | - | $2.19 B(-1.3%) |
| Jun 2015 | - | $2.22 B(+0.8%) |
| Mar 2015 | - | $2.21 B(+0.7%) |
| Dec 2014 | $8.43 B(+1.2%) | $2.19 B(+7.8%) |
| Sep 2014 | - | $2.03 B(-2.9%) |
| Jun 2014 | - | $2.09 B(-1.1%) |
| Mar 2014 | - | $2.12 B(+3.4%) |
| Dec 2013 | $8.33 B(-5.2%) | $2.05 B(-2.4%) |
| Sep 2013 | - | $2.10 B(-7.8%) |
| Jun 2013 | - | $2.27 B(-2.4%) |
| Mar 2013 | - | $2.33 B(+52.3%) |
| Dec 2012 | $8.79 B(-9.9%) | $1.53 B(-37.9%) |
| Sep 2012 | - | $2.47 B(+3.6%) |
| Jun 2012 | - | $2.38 B(-1.5%) |
| Mar 2012 | - | $2.42 B(-178.7%) |
| Dec 2011 | $9.76 B(-30.8%) | -$3.07 B(-158.5%) |
| Sep 2011 | - | $5.25 B(+38.1%) |
| Jun 2011 | - | $3.80 B(+0.5%) |
| Mar 2011 | - | $3.78 B(-1.9%) |
| Dec 2010 | $14.10 B(+24.6%) | $3.85 B(+2.7%) |
| Sep 2010 | - | $3.75 B(+4.2%) |
| Jun 2010 | - | $3.60 B(+24.5%) |
| Mar 2010 | - | $2.89 B(-7.9%) |
| Dec 2009 | $11.32 B(+1.8%) | $3.14 B(+13.8%) |
| Sep 2009 | - | $2.76 B(+2.5%) |
| Jun 2009 | - | $2.69 B(-1.0%) |
| Mar 2009 | - | $2.72 B(-10.1%) |
| Dec 2008 | $11.12 B(+12.2%) | $3.03 B(+10.2%) |
| Sep 2008 | - | $2.75 B(+1.4%) |
| Jun 2008 | - | $2.71 B(+2.7%) |
| Mar 2008 | - | $2.64 B(+3.8%) |
| Dec 2007 | $9.91 B(+15.2%) | $2.54 B(-1.7%) |
| Sep 2007 | - | $2.59 B(+8.7%) |
| Jun 2007 | - | $2.38 B(-1.1%) |
| Mar 2007 | - | $2.41 B(+4.6%) |
| Dec 2006 | $8.60 B | $2.30 B(+0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2006 | - | $2.28 B(-11.3%) |
| Jun 2006 | - | $2.57 B(+44.5%) |
| Mar 2006 | - | $1.78 B(-8.2%) |
| Dec 2005 | $7.32 B(+10.6%) | $1.94 B(+4.2%) |
| Sep 2005 | - | $1.86 B(+3.4%) |
| Jun 2005 | - | $1.80 B(+4.2%) |
| Mar 2005 | - | $1.72 B(-6.9%) |
| Dec 2004 | $6.62 B(+2.9%) | $1.85 B(+20.5%) |
| Sep 2004 | - | $1.54 B(-8.2%) |
| Jun 2004 | - | $1.67 B(+7.5%) |
| Mar 2004 | - | $1.56 B(-6.1%) |
| Dec 2003 | $6.43 B(+23.7%) | $1.66 B(+15.4%) |
| Sep 2003 | - | $1.44 B(-28.5%) |
| Jun 2003 | - | $2.01 B(+43.4%) |
| Mar 2003 | - | $1.40 B(+13.7%) |
| Dec 2002 | $5.20 B(-2.1%) | $1.23 B(-9.3%) |
| Sep 2002 | - | $1.36 B(+0.2%) |
| Jun 2002 | - | $1.36 B(+8.7%) |
| Mar 2002 | - | $1.25 B(-17.1%) |
| Dec 2001 | $5.31 B(+29.4%) | $1.51 B(+7.9%) |
| Sep 2001 | - | $1.40 B(+3.7%) |
| Jun 2001 | - | $1.35 B(+26.3%) |
| Mar 2001 | - | $1.07 B(-1.8%) |
| Dec 2000 | $4.11 B(-15.8%) | $1.09 B(+6.6%) |
| Sep 2000 | - | $1.02 B(+1.9%) |
| Jun 2000 | - | $998.33 M(-0.7%) |
| Mar 2000 | - | $1.01 B(-48.3%) |
| Dec 1999 | $4.88 B(+2.2%) | $1.94 B(+100.7%) |
| Sep 1999 | - | $968.53 M(-4.3%) |
| Jun 1999 | - | $1.01 B(+5.9%) |
| Mar 1999 | - | $954.98 M(-25.1%) |
| Dec 1998 | $4.78 B(+0.9%) | $1.28 B(+10.4%) |
| Sep 1998 | - | $1.16 B(+16.7%) |
| Jun 1998 | - | $989.29 M(-14.2%) |
| Mar 1998 | - | $1.15 B(-9.6%) |
| Dec 1997 | $4.73 B(+8.8%) | $1.28 B(+6.3%) |
| Sep 1997 | - | $1.20 B(+23.6%) |
| Jun 1997 | - | $971.15 M(+3.7%) |
| Mar 1997 | - | $936.67 M(-45.3%) |
| Dec 1996 | $4.35 B(+31.7%) | $1.71 B(+91.4%) |
| Sep 1996 | - | $894.24 M(-15.6%) |
| Jun 1996 | - | $1.06 B(+5.5%) |
| Mar 1996 | - | $1.00 B(+16.7%) |
| Dec 1995 | $3.30 B(+9.5%) | $860.26 M(+10.6%) |
| Sep 1995 | - | $777.58 M(-5.1%) |
| Jun 1995 | - | $819.64 M(-3.1%) |
| Mar 1995 | - | $846.01 M(+2.5%) |
| Dec 1994 | $3.02 B(+7.8%) | $825.30 M(+9.3%) |
| Sep 1994 | - | $754.96 M(+5.8%) |
| Jun 1994 | - | $713.73 M(-1.4%) |
| Mar 1994 | - | $723.98 M(+149.4%) |
| Dec 1993 | $2.80 B(-13.8%) | $290.25 M(-64.7%) |
| Sep 1993 | - | $822.80 M(-8.6%) |
| Jun 1993 | - | $899.90 M(+14.5%) |
| Mar 1993 | - | $786.20 M(-4.1%) |
| Dec 1992 | $3.25 B(+27.0%) | $819.50 M(+10.1%) |
| Sep 1992 | - | $744.40 M(-21.8%) |
| Jun 1992 | - | $951.60 M(+29.8%) |
| Mar 1992 | - | $732.90 M(+7.3%) |
| Dec 1991 | $2.56 B(+16.4%) | $682.90 M(+8.7%) |
| Sep 1991 | - | $628.30 M(-0.5%) |
| Jun 1991 | - | $631.70 M(+2.6%) |
| Mar 1991 | - | $615.70 M(+3.7%) |
| Dec 1990 | $2.20 B(+15.1%) | $594.00 M(+8.6%) |
| Sep 1990 | - | $547.10 M(+0.7%) |
| Jun 1990 | - | $543.20 M(+5.6%) |
| Mar 1990 | - | $514.20 M |
| Dec 1989 | $1.91 B(+8.9%) | - |
| Dec 1988 | $1.75 B(+15.0%) | - |
| Dec 1987 | $1.52 B(+20.9%) | - |
| Dec 1986 | $1.26 B(+16.2%) | - |
| Dec 1985 | $1.08 B(+9.4%) | - |
| Dec 1984 | $990.80 M | - |
FAQ
- What is Abbott Laboratories annual total operating expenses?
- What is the all time high annual operating expenses for Abbott Laboratories?
- What is Abbott Laboratories annual operating expenses year-on-year change?
- What is Abbott Laboratories quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Abbott Laboratories?
- What is Abbott Laboratories quarterly operating expenses year-on-year change?
What is Abbott Laboratories annual total operating expenses?
The current annual operating expenses of ABT is $16.42 B
What is the all time high annual operating expenses for Abbott Laboratories?
Abbott Laboratories all-time high annual total operating expenses is $16.42 B
What is Abbott Laboratories annual operating expenses year-on-year change?
Over the past year, ABT annual total operating expenses has changed by +$763.00 M (+4.87%)
What is Abbott Laboratories quarterly total operating expenses?
The current quarterly operating expenses of ABT is $4.12 B
What is the all time high quarterly operating expenses for Abbott Laboratories?
Abbott Laboratories all-time high quarterly total operating expenses is $5.25 B
What is Abbott Laboratories quarterly operating expenses year-on-year change?
Over the past year, ABT quarterly total operating expenses has changed by +$216.00 M (+5.53%)